Natural Product (NP) Details
General Information of the NP (ID: NP6530) | |||||
---|---|---|---|---|---|
Name |
Farnesol
|
||||
Synonyms |
farnesol; trans,trans-Farnesol; 106-28-5; (E,E)-Farnesol; (2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol; trans-Farnesol; (2E,6E)-Farnesol; 4602-84-0; 2-trans,6-trans-Farnesol; All-trans-Farnesol; Farnesyl alcohol; 3,7,11-Trimethyl-2,6,10-dodecatrien-1-ol; FCI 119a; Inhibitor A2; (E)-farnesol; HSDB 445; 2,6-Di-trans-Farnesol; 2,6,10-dodecatrien-1-ol, 3,7,11-trimethyl-, (2E,6E)-; (2-trans,6-trans)-farnesol; 2E,6E-farnesol; Farnesol (mixture of isomers); UNII-X23PI60R17; 3,7,11-Trimethyl-2,6,10-dodecatrienol; 2,6,10-Dodecatrien-1-ol, 3,7,11-trimethyl-; Farnesol, mixture of isomers; Floral Green; CHEBI:16619; 3,7,11-trimethyldodeca-2,6,10-trien-1-ol; X23PI60R17; (2E,6E)-3,7,11-Trimethyl-2,6,10-dodecatrien-1-ol; trans,trans-3,7,11-Trimethyl-2,6,10-dodecatrien-1-ol; 2,6,10-Dodecatrien-1-ol, 3,7,11-trimethyl-, (E,E)-; ST072172; Farnesol 97+% FCC; MFCD00002918; (E,E)-3,7,11-Trimethyl-2,6,10-dodecatrien-1-ol; FEMA No. 2478; Trimethyl dodecatrienol; EINECS 225-004-1; NSC 60597; EPA Pesticide Chemical Code 128911; polyprenols; transfarnesol; Nikkosome; trans- farnesol; AI3-44561; .beta.-Farnesol; E,E-farnesol; all-trans farnesol; (E,E)farnesol; FOF; trans,trans farnesol; Farnesol (6CI); (E,E,)-farnesol; Farnesol, 95%; (2Z,6Z)-Farnesol; Farnesol (2E,6E); Farnesol, (E,E)-; Farnesol, trans, trans; 2E,6E-Farnesyl alcohol; Spectrum5_002027; trans,trans-alpha-farnesol; DSSTox_CID_12389; DSSTox_RID_78934; trans,trans-Farnesol, 96%; trans,trans-Farnesol, 97%; DSSTox_GSID_32389; SCHEMBL58068; 2-trans-S-6-trans-farnesol; BSPBio_002660; Farnesol, analytical standard; CHEMBL25308; SPECTRUM1501022; (e,e)-FARNESOL 97+%; DTXSID2040789; BDBM11021; CHEBI:26199; CHEBI:28600; HY-Y0248A; AMY33538; BCP22704; ZINC1532860; Tox21_302034; AC-422; BBL027412; CCG-38862; s4941; SBB012426; STL372743; AKOS004907430; LMPR0103010001; MB00132; NCGC00095654-01; NCGC00095654-02; NCGC00095654-03; NCGC00095654-04; NCGC00095654-05; NCGC00255293-01; trans,trans-Farnesol, analytical standard; AS-16107; LS-14447; S409; CAS-4602-84-0; CS-0031456; 06F285; C01126; Farnesol, mixture of isomers, analytical standard; A801411; Q420449; Q-201851; W-109985; BRD-K24656285-001-01-0; Farnesol, mixture of isomers, >=95%, stabilized, FG; (2E, 6E)-3,7,11-trimethyl2,6,10-dodecatrien-1-ol; (2E,6E)-3,7,11-trimethyl-1-dodeca-2,6,10-trienol; (E,E,)-3,7,11-Trimethyl-2,6,10-dodecatrien-1-ol; F1905-7040; (2E,6E)-3,7,11-trimethyl-dodeca-2,6,10-trien-1-ol; Farnesol mixture of isomers stabilized with alpha tocopherol; UNII-EB41QIU6JL component CRDAMVZIKSXKFV-YFVJMOTDSA-N; 2,6,10-Dodecatrien-1-ol, 3,7,11-trimethyl- (8CI,9CI); A2865747-EC66-4B9C-A593-0A066A438904; (2-trans,6-trans)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol
Click to Show/Hide
|
||||
Species Origin | Mosla chinensis ... | Click to Show/Hide | |||
Mosla chinensis | |||||
Disease | Candidosis [ICD-11: 1F23] | Investigative | [1] | ||
Structure |
Click to Download Mol2D MOL |
||||
Click to Show/Hide the Molecular Information and External Link(s) of This Natural Product | |||||
Formula |
C15H26O
|
||||
PubChem CID | |||||
Canonical SMILES |
CC(=CCCC(=CCCC(=CCO)C)C)C
|
||||
InChI |
1S/C15H26O/c1-13(2)7-5-8-14(3)9-6-10-15(4)11-12-16/h7,9,11,16H,5-6,8,10,12H2,1-4H3/b14-9+,15-11+
|
||||
InChIKey |
CRDAMVZIKSXKFV-YFVJMOTDSA-N
|
||||
CAS Number |
CAS 4602-84-0
|
||||
ChEBI ID | |||||
Herb ID | |||||
SymMap ID | |||||
TCMSP ID | |||||
TTD Drug ID |
Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally | ||||||
---|---|---|---|---|---|---|
α. A List of Drug(s) Whose Efficacy can be Enhanced by This NP | ||||||
Fluconazole | Fungal infection | Click to Show/Hide the Molecular Data of This Drug | ||||
Achieving Therapeutic Synergy | Click to Show/Hide | |||||
Representative Experiment Reporting the Effect of This Combination | [2] | |||||
Detail(s) | Combination Info click to show the detail info of this combination | |||||
Molecule(s)
Regulation |
Up-regulation | Expression | FDFT1 | Molecule Info |
Pathway MAP
|
|
In-vitro Model | Candida albicans SC5314 | Microorganism model | Candida albicans | |||
Experimental
Result(s) |
FAR and FAR/FLC affected fitness of C. albicans biofilm and the ERG gene regulation. | |||||
Micafungin + Caspofungin | Click to Show/Hide the Molecular Data of This Drug | |||||
Achieving Therapeutic Synergy | Click to Show/Hide | |||||
Representative Experiment Reporting the Effect of This Combination | [3] | |||||
Detail(s) | Combination Info click to show the detail info of this combination | |||||
In-vitro Model | Candida parapsilosis isolates | Microorganism model | Candida parapsilosis | |||
Candida parapsilosis ATCC 22019 | Microorganism model | Candida parapsilosis | ||||
Experimental
Result(s) |
Caspofungin and micafungin in combination with farnesol showed synergistcant interaction against Candida parapsilosis biofilms. | |||||
Ibandronate + Docetaxel | Click to Show/Hide the Molecular Data of This Drug | |||||
Achieving Therapeutic Synergy | Click to Show/Hide | |||||
Representative Experiment Reporting the Effect of This Combination | [4] | |||||
Detail(s) | Combination Info click to show the detail info of this combination | |||||
In-vitro Model | LNCaP | CVCL_0395 | Prostate carcinoma | Homo sapiens | ||
PC-3 | CVCL_0035 | Prostate carcinoma | Homo sapiens | |||
Experimental
Result(s) |
Ibandronate effectively inhibits growth of prostate cancer cell lines via inhibition of the farnesyl-IPP-synthase and exhibits synergistic effects with docetaxel. |
Target and Pathway | ||||
---|---|---|---|---|
Target(s) | Monoamine oxidase B (MAO-B) | Molecule Info | [5] | |
BioCyc | Superpathway of tryptophan utilization | Click to Show/Hide | ||
2 | Tryptophan degradation via tryptamine | |||
3 | Dopamine degradation | |||
4 | Putrescine degradation III | |||
5 | Noradrenaline and adrenaline degradation | |||
KEGG Pathway | Glycine, serine and threonine metabolism | Click to Show/Hide | ||
2 | Arginine and proline metabolism | |||
3 | Histidine metabolism | |||
4 | Tyrosine metabolism | |||
5 | Phenylalanine metabolism | |||
6 | Tryptophan metabolism | |||
7 | Drug metabolism - cytochrome P450 | |||
8 | Metabolic pathways | |||
9 | Serotonergic synapse | |||
10 | Dopaminergic synapse | |||
11 | Cocaine addiction | |||
12 | Amphetamine addiction | |||
13 | Alcoholism | |||
Panther Pathway | Adrenaline and noradrenaline biosynthesis | Click to Show/Hide | ||
2 | 5-Hydroxytryptamine degredation | |||
3 | Dopamine receptor mediated signaling pathway | |||
Pathway Interaction Database | Alpha-synuclein signaling | Click to Show/Hide | ||
WikiPathways | Tryptophan metabolism | Click to Show/Hide | ||
2 | Dopamine metabolism | |||
3 | Phase 1 - Functionalization of compounds |